Companies House true 2024-05-01 2025-04-30 false 01361825 uk-bus:Director1 2024-05-01 2025-04-30 01361825 uk-bus:Director2 2024-05-01 2025-04-30 01361825 2024-05-01 2025-04-30 01361825 2025-04-30 01361825 uk-bus:EntityHasNeverTraded 2024-05-01 2025-04-30 01361825 uk-bus:FRS102 2024-05-01 2025-04-30 01361825 uk-bus:FullAccounts 2024-05-01 2025-04-30 01361825 uk-bus:AuditExempt-NoAccountantsReport 2024-05-01 2025-04-30 01361825 2024-04-30 01361825 uk-bus:OrdinaryShareClass1 2024-05-01 2025-04-30 01361825 uk-bus:OrdinaryShareClass2 2024-05-01 2025-04-30 01361825 uk-bus:OrdinaryShareClass3 2024-05-01 2025-04-30 01361825 uk-bus:PreferenceShareClass1 2024-05-01 2025-04-30 01361825 uk-bus:PreferenceShareClass2 2024-05-01 2025-04-30 01361825 uk-bus:PreferenceShareClass3 2024-05-01 2025-04-30 01361825 uk-core:ShareCapitalPreferenceShares 2025-04-30 01361825 uk-core:ShareCapitalPreferenceShares 2024-04-30 iso4217:GBP iso4217:GBP xbrli:shares xbrli:shares

Registered Number 01361825

NASH DRUG COMPANY LIMITED

Dormant Accounts

30 April 2025

NASH DRUG COMPANY LIMITED Registered Number 01361825

Balance Sheet as at 30 April 2025

2025 2024
£ £
Called up share capital not paid
237539
237539
Net assets
237539
237539
Issued share capital
237539 Ordinary Shares of £ 1 each 237539 237539
Total Shareholder funds
237539
237539

STATEMENTS

  1. For the year ending 30 April 2025 the company was entitled to exemption under section 480 of the Companies Act 2006 relating to dormant companies.
  2. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
  3. The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
  4. These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

Approved by the Board on 7 November 2025

And signed on their behalf by:
Andrew Caunce, Director